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Abstract 
ICT can play a vital role in facilitating quality care and support for people living with chronic illness. 
Recently, there has been a proliferation of ICT-enabled consumer health devices. These devices can 
enable individual patients more precise monitoring and control of chronic conditions, and can 
generate information and statistics for analysis by health professionals. The adoption of the ICT-
enabled consumer technologies by patients often relies on the co-adoption of related innovations, 
work practices, analytical tools and information systems by their health professionals. In healthcare, 
adoption is influenced by other stakeholders such as health insurers, the patient's family, chronic 
disease support groups, etc. This paper addresses the individual adoption of ICT-enabled innovations 
when multiple stakeholders are involved. We report on a case study of the adoption of ICT-enabled 
“smartpumps” by pregnant women with Type 1 diabetes. We find that the patient should be theorised 
as adopter, but also as influencer under certain conditions. We develop propositions to explain 
adoptive behaviour as the adopter/influencer seeks to achieve congruence of interests in a stakeholder 
network. Our findings help explain why the adoption of ICT-enabled health innovations can occur 
swiftly in some situations, yet proceed slowly in others. 
Keywords: Adoption, Healthcare, ICT, Consumer. 
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1 INTRODUCTION 
ICT can play a vital role in facilitating quality care and support for those affected by chronic diseases 
such as asthma and diabetes. In recent years, various consumer health devices have become 
commercially available, drawing on advances in sensor technology, wireless communications, low-
powered integrated circuits, mobile technology, etc. (Milenković et al., 2006). These devices can 
afford the patient more precise and continuous health monitoring and control of their chronic condition 
(Lenhard and Reeves, 2001). Consumer healthcare devices are often IT-enabled, enabling the patient 
to extract and transmit information generated by the device electronically to their healthcare 
professionals. It is foreseen that consumer healthcare would ultimately integrate in real-time with 
medical information systems in the future (Milenković et al., 2006). To realise such a compelling 
vision, a more in-depth understanding of consumer healthcare adoption within the wider context of 
organisational and institutional practices in healthcare becomes essential. 
From the perspective of individual potential adopter (i.e., the patient), several factors 
complicate the adoption of consumer health ICT. First, adoption actions “do not occur in a vacuum” 
(Orlikowski, 1993, p. 318); they often impact other stakeholders such as the patient's physician, 
specialists, other health professionals, family, support groups, etc. Adoption may necessitate changes 
to these stakeholders’ work processes and routines, and may even require co-adoption of related 
innovations or practices. For example, an endocrinologist might need to adapt his/her work practices, 
or co-adopt information systems to acquire and analyse electronic information transmitted from the 
patient's health care device. In this regard, Alter (2010) suggests the term congruence as a measure of 
the interactions between different work practices or systems in terms of consistency in their form, 
logic, or details (i.e., two entities’ systems/work practices can be considered congruent if their 
information is consistent, their technology is interoperable, etc., even though each entity might have 
different overarching goals and objectives).  
Second, consumer healthcare innovations can involve significant financial outlays. These 
costs are typically borne by third parties such as private and public health insurers who usually require 
extensive evidence of the need, etc. Lastly, considerations such as privacy rules, possible litigation, 
differing standards, etc., all represent barriers to adoption (Rogers, 1995) that can slow down and 
complicate adoption in the healthcare context.  
The objective of this paper is to extend the theory on individual adoption when multiple 
parties contribute to an individual’s adoption process (a situation typical of healthcare but also other 
contexts). Given that the various stakeholders in this situation are effectively independent/autonomous 
agents in their own right, those seeking to advance adoption have to resort to influence as their 
primary mode of agency (See King et al., 1994 for the distinction between power-based and influence-
based agency). Influence can be exerted in a variety of ways (Kipnis et al., 1980; Lee and Sweeney, 
2001; Yukl et al., 1993), but overall the intent is to achieve a desired behavioural response from the 
party under the sway of influence. 
The paper is structured as follows. First, we provide some background on our specific study 
context (the adoption of IT-enabled smartpumps by pregnant women with Type 1 diabetes). We 
review the literature, focusing on theoretical perspectives on the individual adoption of innovations, 
adopter interdependencies, and the literature on influencing tactics. We describe our research method 
and discuss our findings given the extant literature. Based on our study, we put forth a number of 
propositions for further theoretical exploration. We discuss how our findings can help explain why the 
health innovation adoption process can be either swift or protracted depending on the intrinsic 
motivation of the adopter and degree of congruence in a stakeholder network. 
2 THE STUDY CONTEXT 
Type 1 diabetes is an auto-immune condition which can present at any age, although most commonly 
onset begins under 40. It is a significant health problem worldwide. In Australia nearly 1 million 
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people are currently diagnosed with diabetes; about 10-15% of all cases are of Type 1 (Diabetes 
Australia, 2011). People diagnosed with Type 1 diabetes must maintain a regimen of insulin, diet and 
physical activity in order to remain healthy. 
2.1 Diabetes and pregnancy 
Pregnant women with Type 1 diabetes (hereafter PWT1D) and those planning a pregnancy face 
additional medically related challenges and risks. Due to their ‘high risk’ pregnancy they are 
dependent on the support of a range of health professionals. The risks can be ameliorated by achieving 
extraordinary control of their diabetes. One element of this is by more frequent monitoring of their 
blood sugar levels (e.g. from 3 up to 10 times daily) and precise adjustments to insulin doses, during 
pregnancy and while breastfeeding. These considerations impact on the health and wellbeing of both 
mother, and unborn child. 
2.2 Smartpumps 
Smartpumps play a role in the management of Type 1 diabetes for women considering pregnancy and 
those who are pregnant. Smartpumps (Lenhard and Reeves, 2001) used in conjunction with electronic 
blood glucose level (BGL) meters enable much more precise control of blood glucose levels 
(compared to traditional insulin delivery methods such as insulin pens/injections), and in combination, 
can record information/trends for subsequent analysis by health professionals.  
Specifically, in multiple daily injection therapy, it is not always clear how much insulin is 
being used for background and how much is being used for food. In insulin pump therapy, the two are 
clearly separate. Smartpumps allow the user to set a basal rate, or background insulin, to be delivered 
continuously throughout the day and night for the normal body functions without food and allows the 
user to give a bolus, or delivery of insulin, "on demand", when food is eaten. While reports indicate 
that smartpumps have positive outcomes during pregnancy, smartpump adoption is not unproblematic. 
There is a high setup cost to women in terms of both the financial cost of acquiring a smartpump and a 
team who are supportive of smartpump use. 
The adoption of a smartpump impacts on the person with diabetes, but also potentially on the 
work practices of other stakeholders (Goldberg et al., 2010) such as their diabetes educator, 
endocrinologist, and related health professionals (e.g., ophthalmologists, obstetricians). The electronic 
exchange and analysis of blood glucose information pre-consultation, and the discussion of electronic 
information during consultations both imply changes in work practices and the nature of the typical 
consultation between the health professional and patient. Not all health professionals working in the 
diabetes area are necessarily ‘pro-pumping’ (Schade and Valentine, 2006). Due to entrenched work 
practices, lack of awareness, the high cost of the technology, possible legal concerns, the need to 
change routines, etc., many prefer traditional control approaches such as injections/insulin pens and 
paper-based logs of blood sugar levels and other pertinent data. 
2.3 Stakeholders in the diabetes context 
It has long been recognised that the provision of care and support to people with a chronic disease 
such as diabetes is a collaborative team effort (Wilson et al., 2009). In the case of diabetes this 
includes contribution from the person with diabetes, the endocrinologist, the general practitioner, 
related health care specialists, diabetes educators, healthcare insurers, manufacturers of smart pumps 
and related diabetes control technologies, family members and support groups. This complex network 
represents individuals and communities with divergent values and objectives. There are three primary 
activities to facilitate quality care and support: (a) collection of information on the state of the mother 
and baby; (b) dissemination and sharing of relevant information to the healthcare specialists and 
supporters; and (c) collaboration and coordination between different team members for the provision 
of care and support. 
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3 LITERATURE REVIEW: INDIVIDUAL ICT ADOPTION AND 
ADOPTER INTERDEPENDENCIES 
In this section we review research literature that relates to the adoption of consumer health IT 
innovations by individual patients.  
A significant body of research exists on the adoption of innovations by individuals in general 
(e.g., Rogers, 1995) and the individual adoption of IT-related innovations by individuals in particular 
(Brown and Venkatesh, 2005; Davis, 1989; Fichman, 1992; Iivari, 1993; Jeyaraj and Sabherwal, 2008; 
Karahanna et al., 1999; Moore and Benbasat, 1991; Prescott and Conger, 1995; Sarker and Wells, 
2003; Venkatesh et al., 2003).  
Rogers (1995) argues that certain characteristics of innovations, such as relative advantage, 
compatibility, complexity, trialability, and observability, as perceived by individuals, help explain 
their differing rates of adoption. He also categorises adopters according to the average time at which 
they typically adopt an innovation; innovators adopt the earliest, then early adopters, early majority, 
late majority, and finally laggards.  
Sources such as Fichman (1992), Prescott and Conger (1995), and Jeyaraj and Sabherwal 
(2008) provide extensive reviews of the literature that relate to IT adoption in particular. The IT 
adoption studies typically focus on the factors that influence or hinder the adoption of IT-related 
innovations by individuals (Jeyaraj and Sabherwal, 2008). The unit of analysis in these studies is 
typically the “individual”, against a backdrop of a variety of contexts such as the organisation, home, 
communities of practice, etc. (ibid).  
While a significant number of health IT adoption studies exist, to date much of this research 
have been situated in organisational contexts (such as hospitals, general practice, etc) and are often 
focused on patients’ and healthcare workers’ perceptions of the various innovations (e.g., 
Bhattacherjee et al., 2008; Sherer, 2010). As is typical of an emerging research field, there are very 
few literature sources that focus specifically on consumer health IT adoption. The current literature on 
consumer health IT mostly relate to the health technology itself (e.g., design, functionality, benefits for 
the patient) (Lenhard and Reeves, 2001), the integration of the consumer technology with hospital 
systems (e.g., Goldberg et al., 2010; Milenković et al., 2006), and general adoption trends of the e-
health consumer services (e.g., Wilson et al., 2009). For example, Wilson et al. (2009) report on trends 
in the adoption of consumer e-health services in the US. They found that the adoption of informational 
e-health services outside healthcare organisations (i.e., by individuals in their personal capacity) 
increased significantly over the four-year period of their study. Given the sparse literature dealing with 
consumer health IT specifically, we turn to the general and IT adoption literature to frame the research 
issues in the present study. 
Several streams of research exists within the area of individual IT adoption, including the 
importance of the context in which adoption is taking place (Orlikowski, 1993) and adopter 
interdependencies (Fichman, 1992; Jeyaraj and Sabherwal, 2008). Adopter interdependencies and the 
role of other stakeholders within the broader adoption context are of particular relevance to the present 
study. 
3.1 Adopter interdependencies  
Adopter interdependencies exist when others, apart from the focal adopter, co-adopt, or are influenced 
by the innovation in some way. We refer to these other parties as stakeholders throughout the paper. 
For example, some innovations exhibit network externalities (Oliva, 1994) and only become useful 
when others co-adopt the same innovation (e.g., the telephone, fax and e-mail) (Markus, 1987). In the 
healthcare context, it can be argued that electronic health records exhibit some network externalities 
(i.e., benefits accrue only when GPs, specialists, health institutions, etc., all co-adopt the innovation).  
Adopter interdependencies also exist when an innovation is adopted by one party, but related 
innovations/practices need to be co-adopted by others for benefits to accrue. For example, the adoption 
of a hearing aid by patient depends on the adoption of hearing-aid calibration equipment by providers, 
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etc. Similarly, adopter interdependencies exist when an innovation is adopted by one party, but others 
are also influenced/affected in some manner, even though they are not adopting the innovation 
themselves. Adopter interdependencies are particularly prevalent in the healthcare context. Consider a 
patient with asthma who relies on a specialised ventilator. Adopter interdependencies could exist 
between the patient and a number of other stakeholders such as the prescribing doctor, healthcare 
technology vendor, and even family members who might need to assist the patient in case of an 
emergency.  
3.1.1 Influencing tactics 
Jeyaraj and Sabherwal (2008) examined individual IT adoption when adopter interdependencies exist. 
In particular they studied the contextual actions of stakeholders and the adoptive behaviour of the 
focal adopter. They highlight the behaviour of one category of stakeholders which they label 
influencers. Jeyaraj and Sabherwal define influencers as “...those individuals who are responsible for 
enforcing the mandate for the innovation, or those individuals who function as ‘‘champions” of the 
innovation, or those individuals designated as ‘‘change-agents” for the innovation, or those technically 
savvy individuals who possess the expertise to assist others with the innovation (Howell & Higgins, 
1990; Rogers, 1995). Influencers are generally enthusiastic about the innovation and would attempt to 
influence others to adopt the innovation. Influencers are important in the innovation adoption process 
since they reinforce the innovation and its adoption to specific potential adopters in the organization 
on a one-to-one basis over and above the communal actions in the context.” (p. 213-214) . 
According to Jeyaraj and Sabherwal (who draw on the work of Kipnis et al., 1980), influencers 
influence other individuals to change their behaviours using a variety of tactics. In their study, the 
tactics of influencers include building coalitions, appealing to higher authority, bargaining, acting in a 
clandestine manner, presenting rational arguments, applying sanctions, using friendliness and 
ingratiation, and being assertive (c.f., Kipnis et al., 1980). Jeyaraj and Sabherwal view the influencing 
relationship as unidirectional; the influencer engages in tactics in order to exert influence on the 
possible adopter to encourage adoption of innovation. 
3.2 Summary and research questions 
Although there is a significant body of health IT adoption-related research, the majority of the research 
to date has examined health IT adoption from the perspective of health professionals, or in the context 
of healthcare organisations. Less is known about consumer health IT adoption from the perspective of 
the patient who is living with the chronic condition. A more in-depth examination of the adopter role 
seems especially applicable for those who live with a chronic condition and therefore have an intrinsic 
motivation to adopt innovations that could improve their own health and quality of life outside the 
hospital context. 
Furthermore, consumer health IT adoption typically occurs in a context where multiple stakeholders 
may be involved. How does this network of other stakeholders influence the patient’s adoptive 
behaviour? In turn, this raises the question whether adopters themselves are at the same time also 
influencing stakeholders in such contexts. Should the patient (as focal adopter) therefore be theorised 
as an adopter and/or an influencer? 
4 METHODOLOGY 
We used the case study method in this research (Yin, 2003). The case study method enables an in-
depth exploration of a particular phenomenon (in this study, the adoption of smartpumps by PWT1D) 
within a context (in this study, the various other stakeholders involved, specific health issues that these 
adopters face, etc.) (Benbasat et al., 1987; Eisenhardt, 1989). 
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4.1 Research setting and design 
For this study, we chose the PWT1D as the focal unit of analysis (Yin, 2003). In collaboration with 
Diabetes Australia (the peak consumer body and advocacy group representing all people affected by 
diabetes in the country), and in particular their branch in the state of Victoria (hereafter, DA-Vic), we 
assessed the typical stakeholders involved in the decision of PWT1D to adopt smartpumps. These 
stakeholders include the PWT1D’s partner/family, diabetes educators, endocrinologists, related health 
professionals (e.g., her general practitioner, ophthalmologist, obstetrician), technology vendors (who 
manufacture, supply and market smartpumps), and health care insurers (see the stakeholder map 
depicted in Figure 1). 
In the figure, the double headed arrows represent the primary relationships of interest in this 
study, given our focus on the individual as focal adopter. However, it should be noted that formal or 
informal relationships exist between many of the stakeholders in this network (e.g., a diabetes 
educator may involve members of the patient's family as part of the educational process around the 
treatment; vendors tend to provide technical and marketing information to health professionals and 
health insurers, etc). This illustrates the complex dynamics that are typical of such networks. 
Health 
insurers
Advocacy 
groups Related Health 
Professionals
(GPs,  
ophthalmologists,  
obstetricians)
Technology 
vendors 
(smartpump 
manufacturers)
Diabetes 
Educators
Partner/family
and unborn child
Endocrinologists
 
Figure 1. Stakeholder Map with Pregnant Woman with Type I Diabetes as Focal Node 
4.2 Data Collection and Analysis 
We obtained multiple sources of evidence (Yin, 2003) relating to smartpump adoption in metropolitan 
and regional Victoria (Australia). The data collected includes background information (arising from 
our collaboration with DA-Vic) about the use of smartpumps, a DA-Vic documentary on DVD about 
pregnancy and diabetes, demographic information about the number of women aged 18 to 45 (primary 
childbearing ages) with type I diabetes in Victoria and the spread in terms of PWT1D located in 
metropolitan and regional parts of the State. The regional perspective was included because women in 
these areas often have fewer opportunities to access the specialist care, diabetes education, etc., 
compared to their metropolitan counterparts. All this background deepened our understanding of the 
context of PWT1D, and the issues faced pre-pregnancy, during pregnancy, and postpartum. In 
addition, we obtained an understanding of the international perspective in diabetes technology 
adoption through further contextual information supplied by DA-Vic and other sources. 
Data collection occurred between October 2009 and April 2010. The main data source 
included a range of interviews, primarily with PWT1D and some of the stakeholders depicted in 
Figure 1. Specifically, we interviewed 16 PWT1D, 3 Diabetes Educators, 2 Endocrinologists and one 
partner of a PWT1D (refer Table 1). In terms of the other stakeholders in the figure, we consolidated 
information obtained through our interviews, utilised web-based resources, gathered written literature 
(including smartpump brochures) spoke to Diabetes advocates, and attended relevant presentations 
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where technology-related vendors presented at two pregnancy information evenings for PWT1D (refer 
Table 2). This gave us a sense of the perspectives of all the nodes in the stakeholder map.  
In recruiting our interviewees, we sought a balance of regional and metropolitan women, 
women who adopted pumps versus traditional methods (refer Table 3), and women at different stages 
of pregnancy i.e., pre-pregnancy, pregnant, post-partum (Table 1). PWT1D were recruited via DA-Vic 
pregnancy evenings, an advertisement placed in DA-Vic newsletters and using the snowball method 
(i.e., subsequent references by participants). Endocrinologists and diabetes educators were also 
suggested to us by DA-Vic, and again the snowball method was applied. It should be noted that it was 
quite difficult to recruit  health professionals as they tend to be time-poor due to clinical pressures, 
with many on-call on a 24/7 basis. Interviews were audio recorded and transcribed for subsequent 
analysis. 
We conducted a thematic analysis (Miles and Huberman, 1994) of the evidence, working 
through individually and collectively in the research team. In particular, we identified themes 
pertaining to the adoptive behaviour/actions of PWT1D, the different stakeholders involved during 
adoption, and the PWT1D’s interaction with these stakeholders. We then validated our observations 
and interpretations of the data in a workshop with DA-Vic. 
 
Geographic 
Location 
Pre-pregnancy Pregnant Post-partum 
Metropolitan 5 2 4 
Regional   5 
Table 1. Number of Interviews with Women with Type I Diabetes 
 
Diabetes Educators 3 
Endocrinologists 2 
Partners of PWT1D 1 
Table 2.  Number of Interviews with Other Stakeholders 
 
Using traditional methods 5 
Using pumping technology 11 
Table 3.  Number of Interviews Using Pumping Technology 
 
5 CASE STUDY: THE ADOPTION OF SMARTPUMPS BY WOMEN 
WITH TYPE I DIABETES (PRE-PREGNANCY, DURING 
PREGNANCY AND POST-PARTUM) 
In this section we present the key findings from the case study. We describe the relative advantage of 
smartpumps (compared to traditional treatment approaches) and the barriers to adoption (Rogers, 
1995) of the new technology as reported by the PWT1D. We then present themes (Miles and 
Huberman, 1994) emerging from the data analysis, pertaining to how PWT1D influence and seek to 
achieve congruence between the various stakeholders in order to adopt smartpump technology. 
5.1 The Relative Advantage and Barriers to Adoption of Smart Pumps 
Smartpumps allow women to gain better control of their blood sugar levels as they fine-tune insulin 
delivery with much more precision. This has been the experience of many of the participants in this 
study. Other advantages to smartpumps are that they allow women more flexibility and spontaneity in 
terms of eating and exercise and have the added benefit of helping to control morning sickness. 
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PWT1D using syringes/pens have to eat at set times, even when feeling nauseous, while smartpump 
users have a continuous basal dose running in the background which provides some protection, 
allowing more flexibility in the timing of meals. Simply put, PWT1D using smartpumps can eat when 
hungry, and when not feeling nauseous, as long as they continue to count carbohydrates and check / 
respond to prompts on their pumps.  
Better control of blood sugars in PWT1D, particularly in the early stages of pregnancy, leads 
to more positive outcomes of the baby i.e., a decreased chance of malformation, less chance of 
miscarriage, and less chance of a very large baby which may result in increased surgical intervention 
during delivery. For many PWT1D these factors provide a powerful motivation to use a pump to 
ensure as much as possible, that they have a healthy baby.  
At the same time, there are a number of factors which make the adoption of a smartpump 
difficult. Firstly, a major consideration is the cost of buying and maintaining a smartpump - 
smartpumps range from around A$6,000 for a very basic model, to over A$8,000 for more 
sophisticated ones.  Australia generally, has a low rate of private health insurance uptake, particularly 
among those aged 15-34 years (28%). PWT1D without private health insurance have to pay privately 
or take out private health insurance, and wait a year to be eligible to apply for coverage. Ongoing 
consumable costs are also associated with smartpump use.  
Smartpumps are largely user-friendly devices in terms of programming and daily use. Users 
must learn the skills to program, make changes to basal rates, set bolus doses and alarms and change 
cartridges and infusion sets. This requires a high degree of discipline from users who must regularly 
check and respond to the information provided by the device. PWT1D attend a range of medical 
appointments prior to adopting a smartpump, they learn to count carbohydrate intake and test their 
Blood Glucose Levels frequently (10-12 times a day when pregnant), and make constant changes to 
their rates once pumping. 
Other factors that complicate the adoption of smartpumps in Australia include a shortage of 
qualified smartpump trainers, particularly in regional and rural areas. Further, some health 
professionals working in the diabetes space are unsure about the efficacy of smartpumps compared to 
other traditional interventions; consequently they do not actively support their use. Finally, it is 
important to note that there appears to be one primary motivation for PWT1D to adopt a smartpump - 
to ensure a healthy pregnancy and a healthy baby. However, the decision to adopt a smartpump is not 
made independent of other parties, rather PWT1D have to manoeuvre other key stakeholders in 
position to ensure that adoption can occur.  
The following section will discuss these attempts to achieve congruence of stakeholder interests 
in more detail. 
5.2 Influencing Various Stakeholders 
PWT1D learn about smartpumps from a variety of sources; via a health professional, through 
additional diabetes training (e.g. diabetes courses, word of mouth, or Diabetes Australia information 
provision). While PWT1D considering pregnancy may wish to adopt a smartpump, one of our 
interviewees commented on the aspect of timing as part of the adoption decision: 
“I want to get onto the (smart)pump first. The pump is what is forward in my mind at 
the moment. Get onto the pump. Get everything settled down…and under control for 
about a year and then maybe look at starting the whole pregnancy thing.”  
The adoption of a smartpump is not an isolated event for PWT1D; it is a process which has to be 
negotiated and managed within the larger context of the stakeholder network as illustrated with further 
evidence below.  
5.2.1 Convincing Private Health Insurance to Cover Costs 
We found that one of the barriers to adopting a smartpump was the cost of the technology. Our 
interviewees who did not have private health insurance had to meet the cost themselves or join a 
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private health insurance scheme, wait one year to meet timing requirements, and then begin the 
process of applying. One participant outlines this process: 
“I’d been planning on getting a (smart)pump for probably 3 years beforehand. I’d 
picked the model… it was just a matter of getting insurance and waiting a year…. (but) 
It’s not that easy. You‘ve got to go on a waiting list. You’ve got to make hospital 
appointments; you‘ve got to make sure that the doctors are there or the diabetes nurse 
educators are there, and a representative from the company, because all pumps are 
slightly different.” 
Interviewees reported trying to convince private health insurance companies that it was in their best 
interests to support the adoption of the technology, including submitting documentation as proof that 
their diabetes was serious enough to require technological intervention:  
“You need at least eight weeks of documentation to go to the [private health insurance] 
to show the highs and lows - your HbA1c may not tell them that. My last HbA1c was 6.5 
and that’s too good to get [private health insurance] support. So now I’m having (to 
document) highs and lows to show them that I actually should have a (smart)pump. 
Some people let it slide for a while to get that. I think that’s just ridiculous.  Causing 
yourself intentionally bodily harm to get better (results for them) seems quite odd to 
me.”  
Our interviewees argued that while the outlay for smartpumps was costly; over their pregnancy and 
lifespan, the cost was less than private health insurance companies would have to pay for traditional 
treatment. One PWT1D said: 
 “It is a large cost... at the same time $5000 to $8000 for a pump reducing 
complications later in life is not much money at all. So (when) you actually have to 
prove eligibility for it to me it seems a little bit of an unnecessary hurdle. But I guess 
that’s health insurance.” 
5.2.2 Persuading General Practitioners and Other Allied Health Professionals 
Some PWT1D discussed “educating” and informing their General Practitioners and other allied health 
professionals about smartpumps. One interviewee said  
“I went to see my GP and I was talking about the (smart)pumps; he said ‘I really 
haven’t heard anything about it. I don’t know what you’re talking about.” 
Ultimately this PWT1D persuaded her GP that the adoption of a smartpump was in her best interests, 
and he became a valuable ally, providing documentation to support adoption.  
5.2.3 Persuading Diabetes Educators 
Anecdotal evidence from our interviews with Diabetes Educators and PWT1D show that some 
Diabetes Educators do not support the use of smartpumps due to a number of factors including little 
contact with PWT1D (i.e., focusing on type 2 or gestational diabetes instead), rapid changes in 
smartpump technology and personal beliefs. For some PWT1D this means that they have to actively 
persuade their Diabetes Educator that they are a suitable candidate to adopt and manage a smartpump. 
The Diabetes Educator is a key stakeholder in the PWT1D’s network, as he/she provides essential 
training in applying, using and managing a smartpump on a daily basis. Other Diabetes Educators are 
however positive about the use of smartpumps, particularly during pregnancy. One Diabetes Educator 
elaborated: 
“We’re working with smartpumps now that can adjust rates by as little as 0.025 per 
unit.  You get much finer control and it does handle things like vomiting (due to 
9
Scheepers et al.: Consumer Health ICT And The Patient In The Middle: Adopter And/Or
Published by AIS Electronic Library (AISeL), 2011
morning sickness), poor appetite, up in the middle of the night and then after you’ve had 
the baby for things like breastfeeding and all those sorts of things.  It just makes life 
easier.” 
5.3 Tactics for Establishing Congruence between Stakeholders 
Given the contextual complexities in terms of smart pump adoption, our data analysis then turned 
towards specific tactics that the PWT1D engage to establish congruence in their specific stakeholder 
networks in order for the adoption to proceed. 
5.3.1 Educate/ inform stakeholders 
Key stakeholders already working within the Diabetes space are usually aware of smartpumps (even if 
they do not necessarily agree with it). However partners and close family members are often unaware 
of the technologies open to PWT1D. Many of our participants reported that they sought to educate or 
inform family members, particularly husbands or partners, about smartpumps and the implications 
adoption would have for them e.g. cost, time commitment, emergency support etc. PWT1D 
educated/informed others through a variety of means including jointly attending information sessions, 
practical explanations of the technology etc. 
5.3.2 Play Stakeholders against each other  
PWT1D may have to position their various stakeholders against each other in order to facilitate the 
adoption of smartpumps by, for example, enlisting the aid of their GP in sourcing an endocrinologist 
willing to support smartpump adoption. A PWT1D noted: 
“I’m not happy with my endo… I’m trying to work with my GP and get another endo 
that’s familiar with smartpumps and will be able to help me through pregnancy and 
everything.” 
5.3.3 Replacing stakeholders 
We found evidence indicating that some PWT1Ds will actively seek to replace existing stakeholders 
for others who will support their bid to adopt a smartpump. For example, a PWT1D stated: 
 “… so I just swapped endos (endocrinologists)… for the duration of my pregnancy.”  
5.3.4 Migrate to a different stakeholder network 
Compared to replacing one or two stakeholders, we also found evidence that PWT1D migrate from 
their existing stakeholders to a whole new network of stakeholders who are known to be pro-pumping. 
That is, they ally with a whole new set of health care providers (Diabetes Educators, endocrinologists, 
Obstetrician) who are known to be positive about the role of smartpumps during pregnancy. One 
Diabetes Educator in such a pro-pumping network observed:  
“The endocrinologist will usually recommend that they do go on (smart)pumps to 
optimize their glycemic control… we have three that work in our diabetes and 
pregnancy service and the policy is… if at all possible and with the women’s consent of 
course, they go onto a pump.”  
5.3.5 The intrinsic motivation to adopt 
We found evidence that some PWT1D are highly motivated potential adopters who would go to 
extraordinary lengths in order to gain access and ultimately adopt the new technology. Some 
participants independently researched and contacted smartpump vendors independently of their 
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healthcare team, negotiating ways to adopt the technology even prior to informing their Diabetes 
Educator.   
6 DISCUSSION 
This study highlights some of the complexities faced by PWT1D who seek to garner support amongst 
their stakeholders for the adoption of smartpumps. The women in this study made very purposeful 
decisions in seeking to achieve congruence among the various stakeholders involved in their decision 
to adopt smartpumps. Apart from health professionals, other stakeholders included the patient's 
partner/family, health insurers, vendors of smartpumps, diabetes educators, and diabetes advocacy 
groups in the Australian context. 
The extraordinary lengths that the potential adopters would go to in order to gain access to the 
new technology can be understood in the light of the intrinsic motivation to achieve a healthy outcome 
for the mother and baby. This intrinsic motivation, combined with the relative advantage of the new 
technology during a critical period in terms of health, adds a new theoretical perspective on these 
adopters. They are not “passive” potential adopters, just under the sway of other influencers (Jeyaraj 
and Sabherwal, 2008). Rather, they are highly motivated adopters, and in fact, also influencers of other 
stakeholders (almost as innovators/early adopters in the terminology of Rogers, 1995). They actively 
pursue avenues to engage the stakeholders they need to rely upon, drawing on a range of influence 
tactics in order to ensure adoption of the new innovation. 
The various tactics employed by the PWT1D observed in this case have been documented in 
the literature (Jeyaraj and Sabherwal, 2008; Kipnis et al., 1980; Lee and Sweeney, 2001; Yukl et al., 
1993), albeit in the context of organisational behaviour. What is novel though, is that these tactics are 
employed by the adopters themselves rather than those seeking to influence adopters (in contrast with 
some sources, e.g., Jeyaraj and Sabherwal, 2008). This suggests that the adopter and influencer role is 
actually conflated in these situations, deepening the insight about the complex, dual nature of the 
relationship between adopter and stakeholder. 
Our empirical evidence suggests a number of implications for further theory development, 
especially when such ICT-enabled technology adoption hinges on congruence of work practices or 
viewpoints across several stakeholders in a network. We believe the difficulties in achieving this 
congruence of work practices/viewpoints across stakeholder networks, especially prominent in 
healthcare, can help explain the many failures and slow progress in the adoption of ICT innovations 
often reported in this context (e.g., Middleton, 2005). Our evidence in this healthcare study currently 
supports the following propositions, reflecting the situations of (1) complete, (2) partial, and (3) 
little/no congruence of work practices/views regarding the innovation across the stakeholder network: 
• Proposition 1: If there is a high degree of congruence between all stakeholders in terms of their 
work practices/views regarding the healthcare innovation, then adoption proceeds according to the 
predictions of classical adoption theory (relative advantage, observability, trialability, etc.) 
(Rogers, 1995) for those stakeholders who adopt/co-adopt or the innovation/related innovations 
and associated work practices.  
• Proposition 2a: If some congruence exists in terms of work practices/views across the network, a 
highly motivated potential adopter will seek to establish a stakeholder network with a high degree 
of congruence. (In the case study this occurred on several fronts, e.g. by substituting non-congruent 
nodes (such as changing to an endocrinologist/GP who is pro-pumping), raising awareness of 
uninformed stakeholders, and playing stakeholders off against each other). 
• Proposition 2b: If some congruence exists in terms of work practices/views across the network, 
then the adoption process can be protracted, but will likely be successful, as long as the potential 
adopter remains motivated to establish congruence between stakeholders. 
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• Proposition 3: If little/no congruence exists between stakeholders in terms of work practices/views, 
and prospects for establishing congruence are limited (e.g., substituting nodes or migrating to a 
more congruent network), then it is likely that the potential adopter will abandon the attempt to 
adopt the innovation. 
6.1 Limitations and further research 
The findings reported here should be understood against a backdrop of the specific healthcare context 
of this study. Since we focused on the issues facing pregnant women with Type 1 diabetes who adopt 
smart pumps, the empirical base for the study was fairly narrow. However, we anticipate that the 
propositions would be helpful in guiding research in other contexts that involve motivated potential 
adopters, and where congruence between other stakeholders is also a prerequisite for adoption. The 
propositions need to be tested empirically in further research, and against a larger body of empirical 
evidence. 
7 CONCLUSION 
We studied the individual adoption of ICT-enabled innovations when multiple stakeholders are 
involved. We reported findings from a specific case study involving the adoption of ICT-enabled 
“smartpumps” by pregnant women with Type 1 diabetes, and their interactions with multiple 
stakeholders in this healthcare context. We found that these patients should be theorised as adopters, 
but also as influencers under certain conditions. We developed propositions to explain the adoptive 
behaviour of these adopter-influencers in their efforts to achieve congruence of interests in a 
stakeholder network.  
The notion of congruence (or the lack thereof) between stakeholders in this study presents a 
fruitful area for further research and refinement of the understanding of “the adoption context”. Our 
findings suggest that the adoption process will be either swift or protracted depending on the intrinsic 
motivation of the adopter and degree of congruence in a stakeholder network. We conclude that the 
predictions of classical adoption theory (in terms of the time it takes to adopt, etc.) only applies when 
contextual considerations are conducive to adoption (i.e., congruence of stakeholder interests exist). 
These observations can help explain the reasons behind the lack of progress that is often reported 
when novel ICT innovations are introduced in healthcare contexts. 
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